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1. Introduction  
Adequate nutrition is important in the management of children with chronic illnesses. 
Patients who are unwilling or unable to eat will starve. Starvation depletes tissue stores, and 
ultimately leads to impaired organ function and tissue structure. Appropriate caloric intake 
enables growth, promotes tissue repair, and improve immune function. 
Access to the intestinal tract may be via a nasal tube or by the percutaneous route, with 
delivery to the stomach or jejunum. Nasogastric tubes are employed for short- term feeding, 
usually up to four weeks. In children requiring long term tube feeding, nasogastric feeding 
may be uncomfortable, disfiguring and often traumatic. Percutaneous access is usually by 
either endoscopic or radiological techniques. Percutaneous gastrostomy is basically a 
sutureless approximation of the stomach to the abdominal wall. The percutaneous 
endoscopic gastrostomy (PEG) becomes the most popular technique nowadays. 
The first PEG was performed in the pediatric operating room of University Hospitals of 
Cleveland on June 12, 1979 on a four-and-half-month-old child with inadequate oral intake. 
The procedure was performed under sedation and local anesthesia. The child did 
remarkably well. However, because the initial tube used was a 12F catheter with small 
mushroom head, external migration ensued after 3 weeks.  The catheter was changed under 
direct visualization, using a small laparotomy (Gauderer, 2002). Since then the procedure 
has been adopted worldwide for both children and adults. 
Because the procedure is considered minimally invasive, rapid, and associated with low risk 
of complications, and short hospital stay, it has become the preferred method for 
delivering nutritional support in vulnerable pediatric patients. The benefits not only 
include successful nutritional rehabilitation, but also accelerated growth (Craig et al., 
2006, Sullivan et al., 2005)  enhanced carer satisfaction (Avitsland et al., 2006)  and quality 
of life  (Sullivan et al., 2004).  
2. Indications  
The main clinical indications for PEG placement in children are as follows (Table 1): 
2.1 Inability to swallow 
Children with neurological impairment comprise the majority of this category. They often 
have difficulty eating and drinking. These difficulties are due to problems with oro-
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pharyngeal control  (Gisel et al., 1998, Reilly and Skuse, 1992) and esophageal motility  (Ross 
et al., 1988, Heikenen et al., 1999, Fonkalsrud et al., 1995), related gastro-esophageal reflux  
(Ross et al., 1988), and the high risk of aspiration of food and fluids into the lungs (Rogers et 
al., 1994, Morton et al., 1999, Taylor et al., 1994). Among the consequences for these feeding 
difficulties are undernutrition (Stallings et al., 1993, Sullivan et al., 2000), esophagitis 
(Sondheimer and Morris, 1979), recurrent chest infections (Morton et al., 1999), and 
progressive lung disease (Taylor et al., 1994). Much of this feeding difficulty can be 
overcome by giving nourishment through a gastrostomy. Unfortunately, the placement of a 
gastrostomy in a child with neurological impairment does carry some risk, and parents are 
frequently reluctant to have a gastrostomy placed (Sullivan, 1992). Families with affected 
children need better information when making the difficult decision about whether to 
accept or request a gastrostomy for their child. Most children undergoing PEG tube feeding 
showed improved weight gain after PEG tube feeding (Rempel et al., 1988, Shapiro et al., 
1986, Sanders et al., 1990, Brant et al., 1999). Changes in rate of length growth appeared to be 
less predictable and occurred only in a minority of children. The improvement of physical 
growth coupled with improvement in the general health and the family quality of life 
(Stevenson, 2005). Direct aspiration of orally ingested material and saliva may be a reason 
for recommending PEG tube feeding (Brant et al., 1999, Sulaeman et al., 1998). But gastro-
esophageal reflux is also thought to contribute to aspiration indirectly (Morton et al., 1999). 
Both gastro-esophageal reflux and aspiration can occur without symptoms (Rogers et al., 
1994) and the investigations that are often used to diagnose gastro-esophageal reflux appear 
to be unreliable. Therefore, the decision of anti-reflux procedure together with gastrostomy 
may not be easy unless a child’s symptoms are severe despite appropriate medications 
(Puntis et al., 2000, Sullivan, 1999). 
 
   Clinical indications          
1. Inability to swallow, most commonly neurologically 
impaired children 
2. Chronic illnesses with inadequate caloric intake 
                Chronic renal failure 
                Cystic fibrosis 
                Congenital heart disease 
                Childhood cancer 
 Human immune deficiency virus infection (HIV) 
                Crohn’s disease 
3. Unpalatable medication 
4. Permanent enteral access and gastric decompression 
Table 1. Indications for PEG insertion 
2.2 Chronic illnesses with inadequate intake 
Children with chronic illnesses are usually anorexic, have increased metabolic demands and 
usually cachectic. Children with the following conditions fall under this category: 
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2.2.1 Chronic renal disease  
Chronic renal disease is characterized by a predisposition to anorexia and vomiting.  
Poor appetite may be due to abnormal taste sensation (Bellisle et al., 1995), the 
requirement for multiple medications, the preference for water in the polyuric child, and 
elevated level of circulating cytokines, which act through the hypothalamus to affect 
appetite and satiety (Mak et al., 2006). Vomiting may result from gastro-esophageal reflux 
and delayed gastric emptying in association with increased polypeptide hormones 
(Ravelli et al., 1992). 
When the caloric and protein intake become insufficient to maintain growth despite dietary 
manipulation and medication (Rees and Shaw, 2007), enteral feeding is preferred through a 
gastrostomy. Enteral feeding can allow catch-up growth even in infants and young children 
with severe chronic renal failure (Kari et al., 2000). It is better to place the PEG tube prior to 
commencement of peritoneal dialysis in order to decrease the risk of fungal peritonitis (von 
Schnakenburg et al., 2006). 
Children on dialysis have even more problems that affect their nutritional intake. Such 
children are likely to be on fluid restriction, the presence of full abdomen due to indwelling 
dialysate in patients on peritoneal dialysis may affect their appetite, and there may be 
considerable loss of protein in the dialysate. 
Children with chronic renal failure, post renal transplantation tends to improve their 
appetite, and they succeed in the transition to oral feeding, therefore it becomes possible to 
remove the PEG tube (Ledermann, 2005, Pugh and Watson, 2006). 
2.2.2 Cystic fibrosis  
Children with cystic fibrosis (CF) commonly fail to thrive due to increased resting energy 
expenditure (Buchdahl et al., 1988), associated anorexia (Shepherd et al., 1980), increased 
energy requirements associated with chronic respiratory infection (Lapey et al., 1974, 
Kraemer et al., 1978), maldigestion and malabsorption (Lapey et al., 1974).  
Nutritional repletion and intervention involving prescription of energy rich food and fluids, 
optimization of pancreatic enzyme replacement therapy, oral supplements may be required 
(Anthony et al., 1999). However, in a proportion of patients, particularly those with more 
advanced pulmonary disease, these measures alone are insufficient to maintain body weight  
(Durie and Pencharz, 1992). 
Few studies have assessed the efficacy of gastrostomy feeding in malnourished children 
with CF (Efrati et al., 2006, Truby et al., 2009, Oliver et al., 2004, Van Biervliet et al., 2004). It 
has been suggested that the early restoration of nutritional status may result in improved 
weight gain, improved response to treatment for respiratory exacerbations, amelioration of 
the progressive decline in lung function, extended survival, and perhaps improved quality 
of life. 
2.2.3 Congenital heart disease  
Children with heart disease often have a normal birth weight but show poor weight gain 
and cannot maintain their growth after birth. The cause of this thought to be 
multifactorial and may include factors such as inadequate caloric intake, increased oxygen 
consumption, hypermetabolism, reduced absorption, and feeding intolerance (Mitchell et 
al., 1995, Leitch, 2000). These factors reflect the need for increased energy intake, and thus 
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the dietary intervention is often necessary to improve the nutritional status of these 
children.  
Delivering enteral nutritional support through PEG for 15 child with congenital cardiac 
problems was reported to be safe with rare minor complications and no major 
complications, and effective in terms of improving weight gain at 4 weeks and at 6 months 
after PEG tube insertion (Hofner et al., 2000). The rate of gastrostomy complications was 
more when percutaneous radiological technique was used in 58 children with cardiac 
disease. Major complications included intestinal perforation (3.4%) and aspiration 
pneumonia (12.1%). Significant weight gain was observed despite complications (Sy et al., 
2008). 
2.2.4 Childhood cancer 
Almost half of children with cancer experience malnutrition due to numerous tumor- and 
treatment-related factors (Smith et al., 1991, Sala et al., 2004). It is recognized that a 
diminished nutritional status may be a contributing factor for decreased immune function, 
delayed wound healing, and disturbed drug metabolism influencing prognosis (Bosaeus et 
al., 2001, Tisdale, 1997). Children with cancer are particularly vulnerable to malnutrition, 
because they exhibit elevated nutritional needs due to the disease and its treatment. At the 
same time, children have increased requirements of nutrients to attain appropriate growth 
and neurodevelopment (Han-Markey, 2000). It has been demonstrated that adequate 
nutrition is an important determinant for several clinical outcome measures such as 
treatment response, quality of life, and cost of care (van Eys, 1979, Rickard et al., 1986). 
Various types of high energy protein formulas and liquid supplements are offered to 
increase energy density in pediatric patients, but with less success and poor tolerance 
because of taste and smell perception. Children with painful severe mucositis may have 
problem tolerating oral feeding. A PEG is successfully used method with high acceptance by 
oncologists, children, and parents demonstrating improvements in weight gain and reduced 
family frustration due to eating problems (Skolin et al., 2002, Pedersen et al., 1999). The 
placement of a PEG is indicated when oral ingestion is not sufficient to cover the daily 
energy needs. It is rarely associated with more than minor complications. The most common 
complication was superficial wound infection occurred during neutropenic episodes (Skolin 
et al., 2002, Pedersen et al., 1999). 
2.2.5 Human immunodeficiency virus (HIV) infection 
Malnutrition, one of the most common and obvious signs of pediatric human 
immunodeficiency virus (HIV) disease, may influence the infected child’s already 
compromised immune response. In HIV-infected children, reduced growth and lean body 
mass appears early (Miller et al., 1993, Halsey et al., 1990). Gastrostomy tube feedings have 
become a major means of nutrition in children with HIV infection when other oral methods 
fail  (Henderson et al., 1994). HIV-infected children with higher CD4 counts and lower 
weight-for-height z scores are likely to respond favorably to gastrostomy tube feedings and 
had a 2.8-fold reduction in the risk of dying for every positive unit change in weight z score 
(Miller et al., 1995). The HIV-infected children who received gastrostomy tube feeding had 
more complications associated with the tube than has been reported in the non-HIV 
pediatric literature (Marin et al., 1994). The newer combination antiretroviral therapies used 
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to treat HIV-infected children have result in dramatic delays in HIV progression, with 
reduction in the mortality and morbidity. However adherence to highly effective 
antiretroviral therapy in children may be problematic (Matsui, 1997). Reasons for non 
compliance include refusal, drug tolerability, and adverse reactions.  PEG was suggested as 
a mean to administer medications to overcome such problems and improve adherence 
(Temple et al., 2001, Shingadia et al., 2000). PEG also significantly reduced parent reported 
times for medication administration and, therefore, may have the potential to improve the 
quality of life of HIV-infected children and their families (Shingadia et al., 2000). 
2.2.6 Crohn’s disease 
Malnutrition and growth failure are common at presentation in children with Crohn’s 
disease (Kirschner et al., 1978) . Nutritional rehabilitation is often an important part of the 
management of children with Crohn’s disease, but hampered by anorexia and the 
unpalatability of elemental formulas commonly used in children with Crohn’s disease. An 
elemental formula has been shown to be as effective as steroids in reducing the remission of 
active disease while avoiding the negative effects on growth (Sanderson et al., 1987). It has 
been suggested that the more palatable polymeric formulas can be used for treatment of 
active Crohn’s disease rather than the unpalatable elemental formulas. Large amounts are 
required to be consumed daily with no solid food ingestion in order to achieve such 
therapeutic effect, and this may remain difficult to take by mouth. Nasogastric tube has been 
used for this reason (Belli et al., 1988), but has the advantage of being uncomfortable, 
disfiguring, and embarrassing for the child or adolescent if the tube left in place during the 
day time. A PEG can overcome this problem as it is hidden under clothing and is not visible. 
The use of PEG in children with Crohn’s disease to deliver enteral nutrition has been 
reported to be safe and effective (Israel and Hassall, 1995, Pashankar and Israel, 1997, 
Cosgrove and Jenkins, 1997). Most of the complications of gastrostomy were minor and 
easily treatable. Closure of the gastrostomy tract after removal was almost complete. Only 
one study reported no closure of the gastrocutaneous fistula after PEG removal in one 
patient requiring surgical closure (Israel and Hassall, 1995). PEG remains a good and safe 
option if nasogastric tube feeding is not possible. 
2.3 Unpalatable medications 
Occasionally, PEG can be used in children with long-standing renal or cardiac failure who 
are dependent on large quantities of drugs for survival but resist medication provided orally 
(Gauderer, 2002). 
2.4 Permanent enteral feeding 
Patients with limited intestinal function, such as short bowel syndrome (Buchman, 2007)and 
intestinal pseudo-obstruction (Michaud et al., 2001) may benefit from PEG. PEG tube can 
also be used for gastric decompression in patients with intestinal pseudo-obstruction. 
3. Contraindications  
The contraindications for PEG insertion are related to conditions that cause pharyngeal or 
esophageal obstruction, interfere with gastrostomy site identification, or have been 
identified as being more likely to produce complications (Table 2). 
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Contraindications          
Patients who are unfit for endoscopy 
Pharyngeal / esophageal obstruction 
Active coagulopathy  
Portal hypertension with gastric varices 
Severe ascites 
Peritoneal dialysis 
Epidermolysis bullosa 
Significant kypho-scolisosis when access to the stomach may be compromised 
Failure of translumination through abdominal wall or clear point of indentation 
Table 2. Contraindications for PEG insertion 
4. PEG placement 
4.1 Technique 
The ‘pull’ technique described by Gauderer and Stellato is recommended and is probably 
the technique most widely employed (Fig.1).  After preparation of the abdomen, 
administration of prophylactic antibiotic and preparing the appropriate PEG equipment, 
under general anaesthesia, a flexible gastroscope appropriate to the size and weight of the 
child is passed into the stomach, which is gently insufflated. The abdominal wall is 
transilluminated by the endoscope. The assistant’s finger then indents the anterior 
abdominal wall, and this indentation must be seen clearly through the endoscope to confirm 
close apposition of the stomach to the venteral abdominal wall. A small skin incision is 
made at the intended gastrostomy site. The percutaneous needle and trocar is passed 
directly into the stomach under endoscopic vision. The guidewire is introduced through the 
needle and grasped by the endoscopist’s snare. The scope is gently withdrawn, bringing the 
guidewire with it. An appropriately sized PEG tube is looped to the thread and lubricated 
along its whole length to enable smooth passage through the throat and oesophagus. The 
thread is gently pulled back from the abdominal insertion site and the PEG placed in 
position. The outer flange of the tube is positioned loosely against the anterior abdominal 
wall. The opposition of the inner flange with the gastric wall can be checked by repeat 
endoscopy.  
4.2 Post-operative care 
Postoperatively, the child will be closely monitored. The PEG tube should not be used for 24 
hours. Feeding usually start with small amount of oral rehydration solution and then 
gradually increased to the desired volume. It is generally best to use diluted formulas 
(quarter-strength or half-strength) and then advance the diet first in volume and then in 
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concentration over 3-4 days. Inability to tolerate increased volume is evident by abdominal 
distension, vomiting, or increased gastric residuals. Inability to tolerate increased osmolarity 
is evidenced by diarrhea. Once the child is able to tolerate formula sufficiently in volume 
and concentration, intravenous fluids can be discontinued. Initially, bolus feeding can be 
delivered slowly using enteral feeding pump several times a day. Gastric residuals should 
be checked before application of every bolus of enteral feeding. Careful assessment of the 
gastric residuals may help in improving feeding tolerance and minimising the risk of 
pulmonaray aspiration. Children who are taking medications for seizures will have their 
medications converted to an intravenous form until they are able to tolerate gastric route of 
administration. 
 
 
 
 1a 1b 1c 
 
 1d 1e 1f 
 
 1g 1h  1i 
Fig. 1. The technique of PEG insertion.1a. The main PEG equipment including, a PEG tube, a 
guidewire, a needle with a trocar and a snare. 1b. Abdominal wall transillumination by the 
endoscope with testing for indentation. 1c. Making a small skin incision at the intended 
gastrostomy site. 1d. Passing the needle and trocar directly to the stomach under endoscopic 
vision. 1e. Passing the guidewire through the needle. 1f. Grasping the guidewire by the 
snare to bring through the mouth. 1g. Pulling the guidewire and the anchored tube back 
from the abdominal insertion site. 1h. Checking the opposition of the inner flange with the 
gastric wall. 1i. PEG tube after insertion 
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5. Feeding through PEG tube  
In Infants less than 12 months of age, an infant formula should be used. In patients with 
high caloric needs or with poor tolerance to increased formula volume, the formula may 
be concentrated and/or modular nutrients, such as glucose polymer or lipid, may be 
added. Infants with Cow’s milk protein allergy, gastrointestinal maldigestion or 
absorption, and short bowel syndrome may benefit from amino acid-based or casein-
based formulas.  
Older children may be offered any of the following options depending on the underlying 
disease and the socio-economic status: 
5.1 Polymeric feeds 
Polymeric feeds are the most commonly used enteral feeds. Most children will tolerate a 
polymeric formula. They contain whole protein as a nitrogen source and energy of 1 
kcal/ml. They are lactose and gluten free. Moreover they contain enough vitamins, trace 
elements and essential fatty acids to prevent deficiencies. Adult formulas should be 
avoided because the caloric-to-nutrient ratio is inadequate for children. Their use may 
result in calcium, phosphorus and vitamin deficiency, especially in patients with low-
caloric needs. 
5.2 Elemental feeds 
Elemental feeds contain either amino acid or hydrolyzed protein. They are relatively 
expensive with unpalatable taste. It should be used only in situations where there is 
profound impairment in the gastrointestinal digestive and absorptive functions. 
5.3 Blenderised food 
This is used in many developing countries primarily because it is cheaper than 
commercially prepared feeds. It is viscous and chunks of food may block the feeding tube 
and increase the risk of complications. Feeding contamination is a further risk that may 
predispose to fungal growth in the lumen of the tube (Fig. 2). 
 
 
 
 
Fig. 2. Fungal contamination of the PEG tube 
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6. Care of the PEG tube  
The care of the child with the PEG differs from that of adults, because of the child’s smaller 
yet growing body and because nutritional needs change in time. Moreover, children, 
especially if chronically underfed, have very sensitive skin that must be protected effectively 
(Hagelgans and Janusz, 1994). Two main problems are the accurate selection of a properly 
sized device and then frequent checks and replacement with a more suitable size if 
necessary. The device should grow with the child. It must be as small as possible; both to 
minimize annoyance to the child, but it also must prevent leakage of gastric content or 
pressure necrosis and allow feeding to pass through easily.  
It is important to secure the external flange of the tube nearly 3 mm above skin level  
(Ricciardi and Brown, 1994) to prevent leakage of the gastric content and to allow freedom 
of movement, which is very important for children to avoid traumatizing the gastric mucosa 
or pulling the bumper into the tract. It also allows air circulation to the skin around and 
underneath the disc to avoid pressure necrosis. 
Skin care includes careful daily control of the position of the external flange with rotation 
and careful cleaning of the skin near the gastrostomy. It is important to protect the skin with 
zinc oxide cream or with absorbent powder or paste if there is any leakage (Hagelgans and 
Janusz, 1994). 
Tube obstruction can easily occur. It is necessary to flush with 10 to 15 ml warm water 
before and after any introduction. You may need to flush only after feeding in very small 
babies. Food must be fluids such as liquid enteral formula. Medicine must be well 
dissolved before administration through the tube. If the tube is blocked, it should be 
flushed with a solution of water and half a capsule of crushed and dissolved pancreatic 
enzymes. 
Bolus feeding must take at least 20 minutes and can be administered by a gravity  
flow system, by pump, or by syringe. If the child has fever or when the weather is warm, 
it is necessary to administer additional water, especially if the child is exclusively fed by 
tube. 
In children with PEG oral function should always be stimulated. Babies can be provided 
with a dummy especially during meals while older children can be offered something to 
chew or suck, such as chewing gum, piece of bread etc. It can comfort them and help the 
anatomical and functional development of the mouth (Tawfik et al., 1997). Mouth cleaning 
should be performed daily to allow a healthy growth of teeth. 
7. Replacement of the PEG tube  
Once placed, PEG tubes are left in situ until signs of cracking appear, usually after 12 
months. Damaged tubes need replacing; this can easily be done at bedside, with balloon 
gastrostomy. Initial PEG needs to be removed before replacement. PEG removal techniques 
are varied. PEGs may be removed endoscopically by grasping the inner flange with a snare 
or basket and delivering it via the oral cavity in a retrograde fashion after cutting the 
external tube at skin level. Alternatively, the device can be removed percutaneously by 
traction provided that the inner flange is collapsible. This approach precludes the need for 
endoscopy unless complications are anticipated or encountered. The third approach 
involves cutting the device at skin level and allowing the inner flange to pass via the 
www.intechopen.com
 
Gastrostomy 34
alimentary tract (‘‘cut and push’’ technique). This is commonly performed in adult practice, 
but is generally thought to be unacceptable in children due to risks of esophageal and 
intestinal obstruction. Esophageal obstruction, perforation, mediastinitis, retropharyngeal 
abscess formation, gastric outlet, intestinal and ileostomy obstruction, enterocutaneous 
fistula formation, tract disruption and death have been variously described with PEG 
removal (Yaseen et al., 1996, Siegel and Douglass, 2004, Palmer et al., 2006, Mollitt et al., 
1998, Lattuneddu et al., 2003, Kobak et al., 2000, El-Rifai et al., 2004). Traction removal is 
performed under general anesthesia in children and involves application of a significant 
pulling force to deliver the device in full. Dilatation of the tract may be required in some 
cases. 
For PEG replacement, parents may prefer a skin-level gastrostomy. This option should not 
be considered until the PEG tube has been in situ for at least 3 months, ensuring that the seal 
between the stomach and abdominal wall is intact and thus avoiding peritoneal soiling. 
Different types of skin-level replacement gastrostomy tubes including Bard® mushroom-
shaped tube and the MICKEY® balloon type tube (Fig.3) are available. These tubes differ in 
the manner in which they are inserted and secured to the abdominal wall. The MICKEY® 
tube is inserted without using a stylet, while Bard® tube is inserted with assistance of a 
stylet. In addition, the MICKEY® tube is secured by a balloon, while the Bard® tube is 
secured by a mushroom-shaped tip. The MICKEY® tube can easily be inserted at bedside 
without the need for endoscopy or dye study to confirm location. The Bard® tube insertion 
using a stylet requires some force. This may increase the risk of disrupting the fistula tract 
(Fox et al., 1997).  It requires endoscopy or dye study for confirmation. Replacement of skin-
level devices may be required if the initial device gets blocked, dislodged, or poorly secured, 
especially after balloon rupture when using The MICKEY® tube. When gastrostomy tube 
dislodged, timely replacement is important because the fistulous tract will begin to close 
within hours, making subsequent replacement more difficult. If commercial replacement 
skin-level devices are not available, a similar size Foley catheter can be temporarily 
inserted. 
 
 
 
 
Fig. 3. Skin-level gastrostomy tubes 
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8. Complications of the PEG tube  
The peri-operative and post-operative complications of the PEG tube are summarized in 
Table 3. 
 
Complications        
         1.    Peri-operative complications 
                Tension pneumoperitoneum 
                Peritonitis  
                Esophageal perforation 
Intra-abdominal bleeding 
         2.    Post-operative complications 
Wound infection 
Necrotizing fasciitis 
Granulation tissue 
Buried bumper syndrome 
Tube migration 
Inadvertent tube removal 
Bloody PEG aspirate / hematemesis 
Bowel perforation 
Gastroesophageal reflux and pulmonary aspiration 
Table 3. Complications of  PEG insertion 
8.1 Peri-operative complications 
8.1.1 Tension pneumoperitoneum  
Benign pneumoperitoneum is common after PEG tube insertion, with reported incidence of 
over 50% (Hillman, 1982, Gottfried et al., 1986, Wojtowycz et al., 1988). Conservative 
management of patients with pneumoperitoneum, who have undergone a recent PEG in the 
absence of additional symptoms, is suggested. It should be of concern if the intraabdominal 
air is worsening or when it is found in the presence of signs of peritonitis, portal and/or 
mesenteric venous gas, systemic inflammatory response and/or sepsis (Wojtowycz et al., 
1988). It may occasionally be a sign of possible bowel injury (Milanchi and Allins, 2007). A 
tension pneumoperitoneum may occur with excessive endoscopic insufflations and a 
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large leak occurs around the gastric needle entry site (Kealey et al., 1996).This can result in 
rapid respiratory embarrassment and cardiopulmonary arrest. Urgent management 
involves cessation of insufflations, gastric aspiration through the endoscope and 
peritoneal decompression via a large cannula placed percutaneously into the peritoneal 
cavity. 
8.1.2 Peritonitis  
Peritonitis occurring shortly after PEG insertion is either due to associated visceral trauma 
(usually colon), or due to gastric leakage because of separation of the stomach from the 
anterior abdominal wall (Kimber et al., 1998). Delay in making the diagnosis and institution 
of appropriate treatment may result in death (Lowe et al., 1997). Children with peritonitis 
may develop abdominal distension, guarding and generalized abdominal tenderness, with 
tachycardia, and pallor, and may be fever. Their clinical condition progressively 
deteriorates. Laparoscopy or laparotomy is warranted after stabilization for children with 
suspected peritonitis. PEG placement in children with chronic renal failure following 
initiation of peritoneal dialysis is associated with a high risk of fungal peritonitis (von 
Schnakenburg et al., 2006, Ledermann et al., 2002). The mortality and morbidity reported 
create more apprehension of recommending the PEG approach after chronic peritoneal 
dialysis has been initiated. At present, the evidence would favor placement of the 
gastrostomy early, before or preferably at the same time as peritoneal catheter insertion 
(Watson, 2006). 
8.1.3 Esophageal perforation 
Esophageal perforation is a rare complication that occurs as a result of using inappropriately 
large gastroscope in small infants or due to poor technique in retrieval of the guidewire 
especially if metallic guidewire is used (Beasley et al., 1995, Haynes et al., 1996). The 
presence of unrecognized esophageal stricture or abnormal fragile mucosa such as 
epidermolysis bullosa can be a predisposing factor for esophageal perforation (Haynes et 
al., 1996). This complication can be avoided with careful examination of the patient, and 
with using an appropriate gastroscope suitable for the age and body weight of the child. 
Metallic guidewires are not commonly used nowadays and being replaced with softer 
guidewires. 
8.1.4 Intra-abdominal bleeding 
PEG can be associated with life-threatening bleeding, especially when multiple needle 
punctures have been made. Acute hemorrhage following PEG is rarely reported (Lau and 
Lai, 2001, Wiggins et al., 2007). Unsussceeful passage of the needle could have caused the 
gastric artery branch laceration or breaches in the splenic and superior mesenteric veins or 
due to a liver laceration. It presents with unexplained post-procedure hypotension. Early 
recognition and treatment are essential. 
8.2 Post-operative complications 
8.2.1 Wound infection  
PEG is a foreign body, and therefore creates and maintains a potential nidus for bacterial 
colonization. Children who require gastrostomy are often malnourished and have other 
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medical problems that make them more susceptible to gastrostomy wound infection(Fig. 4). 
Approximately 10% of children develop erythema and tenderness at the insertion site 
(Khattak et al., 1998). The most common causative organism was staphylococcus aureus 
(Saadeddin et al., 2005, Ahmad et al., 2003). Children tend to harbor polymicrobial aerobic-
anaerobic flora and Candida at the gastrostomy site wound infection (Brook, 1995). Factors 
that contribute to the development of infection may include gastric acid leakage and 
pressure areas from an excessively tight tube (Iber et al., 1996, Bell et al., 1995). Preventing 
measures including checking the position of the exteranal flange, cleaning the skin and 
rotating the tube daily can be followed. Meta-analysis of randomized-controlled trials of 
antibiotic prophylaxis prior to PEG insertion in adults (Jafri et al., 2007) has shown that 
prophylactic antibiotics are effective in reducing the incidence of PEG site wound infection. 
Both cephalosporin-based prophylaxis, such as cefazolin and penicillin-based prophylaxis, 
such as co-amoxiclav are equally effective. If infection diagnosed early, oral broad-spectrum 
antibiotics for 5-7 days may be all that is required for a PEG site infection. If there are more 
systemic signs, intravenous broad-spectrum antibiotics coupled with local wound care are 
necessary.  
 
 
 
 
Fig. 4. Wound infection with associated cellulitis 
8.2.2 Necrotizing fasciitis  
A rare but potentially life-threatening complication is the development of necrotizing 
fasciitis. Children with pre-existing wound infections, malnutrition, and impaired immunity 
are at increased risk (Fox et al., 1997, Farrell et al., 1988). The microbiology of necrotizing 
fasciitis is complex. Multiple aerobic and anaerobic microorganisms display synergy and are 
responsible for the lethality of this condition (Giuliano et al., 1977). Management consists of 
broad spectrum intravenous antibiotics and aggressive surgical debridement. 
8.2.3 Granulation tissue formation  
Granulation tissue following insertion is common (Fig.5). It may occur in response to 
chronic leakage or infection. The granulation tissue can cause discharge, irritation, and 
discomfort. It can bleed in response to trauma.  Frequent topical application of silver 
nitrate is often required and recurrence is common. It is important to protect the 
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surrounding normal skin with petroleum jelly during cauterization with silver nitrate to 
avoid chemical burns. Daily cleaning of the stoma and rotation of the PEG tube may help 
in its prevention. 
 
 
 
 
Fig. 5. Granulation tissue formation 
8.2.4 Buried bumper syndrome  
Buried bumper syndrome is a rare but serious complication of PEG. Published experience in 
children with buried bumper syndrome is very scares (Furlano et al., 2008, Kohler et al., 
2008, Hodges et al., 2001). The bumper becomes lodged anywhere between the gastric wall 
and the skin along the PEG tract. Partial or complete growth of gastric mucosa over the 
internal bolster may occur.  The inability to infuse the feeding formula through the tube and 
leakage around the tube with abdominal pain are the most common manifestation 
(Schwartz et al., 1989). Other symptoms that may be experienced are erythema and edema at 
the gastrostomy site. The endoscopic examination may reveal small irregular slit or a raised 
mount of the mucosa at the previous tube site. A buried bumper should be removed even if 
the patient is asymptomatic, because of the risk of tube impaction in the abdominal wall 
and/or gastric perforation. Computed tomography and ultrasonography can be helpful in 
localizing the bumper and in deciding the appropriate approach for removing the PEG 
either surgical or endoscopic. A number of approaches have been used for the treatment of 
buried bumper syndrome. Initial reports used incision of the skin and dissection to remove 
the impacted bumper, followed by insertion of the replacement tube (Shallman et al., 1988, 
Nelson, 1989, Lee, 1990). Another strategy involves placing a guidewire through the 
impacted tube, followed by pushing the impacted bumper into the stomach using dilators 
externally. The bumper is removed endoscopically and replacement tube is inserted through 
the fistula (Klein et al., 1990, Ma et al., 1995). The selected method has to be safe and should 
be tailored to the individual patient’s needs. 
8.2.5 Gastrostomy tube migration  
The inner flange may enter the pylorus causing complete or partial obstruction (Hussain 
and Thambidorai, 2000, Berry and Vellacott, 1992). If the PEG is within mobile bowel it may 
act as an axis for volvulus causing intestinal obstruction (Waxman et al., 1991, Senac and 
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Lee, 1983). This complication occurs if the PEG has been inserted in the distal antrum, close 
to the pylorus. This complication can be avoided by careful placement of the PEG on the 
greater curve, proximal to the antrum and pyloric canal. 
8.2.6 Inadvertent tube removal  
PEG tract maturation usually occurs within the first 7-10 days but may be delayed up to 4 
weeks in the presence of malnutrition. Inadvertent PEG tube removal can rarely occur 
(Larson et al., 1987, Dwyer et al., 2002). Irritable and hyperactive children are more liable to 
this complication. A PEG tube accidentally removed before the PEG tract maturation 
completed, should be replaced endoscopically. The stomach and the abdominal wall can 
separate from each other, resulting in free perforation.  If the PEG tube is dislodged less than 
one month after placement, repeat endoscopy should be performed to replace the tube.  
When recognized early, the replacement PEG tube can be placed either near or even through 
the same PEG tube site (Galat et al., 1990). Blindly reinserting a new tube may lead to its 
placement inside the peritoneal cavity. If recognition is delayed, the patient should be kept 
NPO (nothing per oral), a nasogastric tube should be placed, and broad-spectrum antibiotics 
should be started. A new PEG should be placed after 7-10 day. Surgical exploration is 
indicated if signs of peritonitis/sepsis are present. A replacement tube can be placed 
without endoscopy through presumably mature tract, when a PEG tube dislodged more 
than one month after placement. 
8.2.7 Bloody PEG aspirate / hematemesis  
Gastrointestinal bleeding after PEG placement has been reported rarely in children (Kazi et 
al., 1997, Weiss et al., 1999). If the PEG flange is loose and mobile within the stomach it can 
irritate the gastric mucosa, and if too tight it can erode the gastric wall by pressure necrosis. 
Either process may lead to gastric bleeding. Most patients present with bleeding between 
two weeks and 6 months. Delayed presentation after 12 years from PEG placement was 
reported in one child.  (Weiss et al., 1999). Because upper gastrointestinal bleeding is not 
always related to the PEG, endoscopy is recommended for diagnosis. Esophagitis and 
gastritis may both occur in chronically ill children, especially in neurologically impaired 
children with reflux esophagitis.  
8.2.8 Bowel perforation  
Gastro-colo-cutaneous fistulae may occur rarely when the colon is inadvertently punctured 
and traversed during PEG placement (Gauderer, 1991, Hacker and Cattau, 1987). Patients 
may present acutely with colonic perforation and peritonitis (Kimber et al., 1998). More 
commonly, patients present chronically with stool leaking around the PEG tube or through 
the stoma during tube removal or replacement. The diagnosis is made using contrast 
radiography via the PEG tube. In most cases, there is no evidence of intraperitoneal leakage 
or gastro-colic fistula. Management consists of removing the tube and allowing the fistula to 
close (Berger and Zarling, 1991). Should the patient develop signs of peritonitis or the fistula 
fail to close, surgery is often required. 
To avoid this complication, the introducing needle should not be inserted into the stomach 
without adequate gastric insufflations, appropriate transillumination, and endoscopically 
visible focal indentation upon external palpation.  
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8.2.9 Gastroesophageal reflux and pulmonary aspiration  
Gastroesophageal reflux is a common problem in neurologically impaired children (Bozkurt 
et al., 2004, Gangil et al., 2001). Children with symptoms of reflux who do not respond to 
medical therapy or with evidence of pulmonary aspiration caused by their reflux should 
undergo a surgical gastrostomy along with an anti-reflux procedure. In children without 
symptoms of reflux or with mild reflux responding well to medical treatment, an 
endoscopic percutaneous approach may be used. There is no role for a prophylactic anti-
reflux procedure (Sulaeman et al., 1998, Khattak et al., 1998, Isch et al., 1997). The choice 
between a gastrostomy with or without an anti-reflux procedure has to be carefully 
evaluated because the failure rate and the incidence of major complications are high in 
neurologically impaired children undergoing anti-reflux procedure (Borgstein et al., 1994). 
In difficult cases, it may be useful to attempt a trial of nasogastric feeds for one month to 
assess tolerance before making a decision. It has been suggested that symptomatic 
Gastroesophageal reflux occurs frequently after PEG (Cameron et al., 1995). Pulmonary 
aspiration has been rarely reported in children following percutaneous gastrostomy feeding 
(Morton et al., 1999, Sy et al., 2008). It is unclear whether this is a consequence of the change 
in volume, consistency and composition of the feeds or a consequence of the procedure. If 
this problem occurs, medical treatment with prokinetics and changes in the formula or in 
the rate and volume of feeds should be attempted before restoring to an anti-reflux 
procedure.  
9. Conclusion 
PEG insertion in children who cannot achieve adequate oral intake is an established route 
for providing long term enteral nutrition. Feeding through PEG tube helps improving the 
physical growth and general health of the chronically ill patients, with subsequent effect on 
the family quality of life. The procedure is associated with frequent minor morbidity. 
Awarness of these complications and the use of preventive strategies can allow the 
endoscopist to maximize outcomes and to identify complications early. 
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